Jonathan Fleming's Net Worth

$0

Estimate Recalculated Nov 1, 2024 09:23AM EST

Who is Jonathan Fleming?

Jonathan Fleming does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Glori Energy Inc., Trubion Pharmaceuticals, Inc, Cyberkinetics Neurotechnology Systems, Inc., AVALON PHARMACEUTICALS INC, Radius Health, Inc., Xencor Inc, ACADIA PHARMACEUTICALS INC, Ceres, Inc., SALMON EXPRESS INC, MEMORY PHARMACEUTICALS CORP, Solexa, Inc., IMCOR PHARMACEUTICAL CO, and CRITICARE SYSTEMS INC /DE/.

SEC CIK

Jonathan Fleming's CIK is 0001262294

Past Insider Trading and Trends

2004 was Jonathan Fleming's most active year for acquiring shares with 1 total transactions. Jonathan Fleming's most active month to acquire stocks was the month of May. 2009 was Jonathan Fleming's most active year for disposing of shares, totalling 1 transactions. Jonathan Fleming's most active month to dispose stocks was the month of December. 2004 saw Jonathan Fleming paying a total of $0.00 for 20,000 shares, this is the most they've acquired in one year. In 2009 Jonathan Fleming cashed out on 10,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Trubion Pharmaceuticals, Inc No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5,180.19%
2.16M
—
—
2.2M
Oct 23
Form 4
∞
41.61K
$13.00
$540,982.00
41.61K
Oct 17
Form 3
—
0
—
—
0
No matching records found

Cyberkinetics Neurotechnology Systems, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+8.58%
833.33K
$1.20
$1,000,000.80
10.54M
Oct 18
Form 4
+34.69%
2.5M
$1.20
$3,000,000.00
9.71M
Sep 26
Form 4
+4.62%
318.5K
$3.00
$955,503.00
7.21M
Nov 4
Form 3
—
0
—
—
0
No matching records found

ACADIA PHARMACEUTICALS INC (ACAD) Snapshot price: $16.07

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 29
Form 4
+22.78%
586.4K
$6.82
$4,000,023.96
3.16M
Apr 20
Form 4
+112.31%
2.6M
$7.00
$1,995,000.00
4.91M
Jun 2
Form 3
—
0
—
—
0
No matching records found

Solexa, Inc. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.14%
552.01K
$4.00
—
3.05M
Jul 12
Form 3
—
0
—
—
0
No matching records found

AVALON PHARMACEUTICALS INC No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+861.30%
753.64K
$10.50
$1,904,700.00
841.14K
Oct 4
Form 3
—
0
—
—
0
No matching records found